抗栓论坛-3 房颤患者管理及抗凝治疗 源自亚洲，为“凝”而来
Antithrombotic Forum-3 Management and Anticoagulation Therapy of Patients with Atrial Fibrillation Originated in Asia, for Coagulation
11/23 10:00-12:10
多功能B
（一楼） (多功能B
(1F))
（一楼） (多功能B
(1F))
-
11:00- 12:00
-
10:00- 11:00
-
10:00- 11:00
-
11:00- 12:00
-
11:00-12:00
-
10:00-11:00
-
11:00-12:00
-
10:00-11:00
-
10:00-11:00
-
11:25-11:45NOAC剂量规范的深层逻辑和价值解析Deep Logic and Value Analysis of NOAC Dose Specification
-
11:05-11:25探讨房颤合并冠心病患者的抗栓治疗策略Investigation of the Antithrombotic Treatment Strategy of Patients with Atrial Fibrillation Complicated with Coronary Heart Disease
-
10:25-10:45《老年心房颤动诊治中国专家共识（2024）》解读Interpretation of Chinese Expert Consensus on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly (2024)
-
10:45-10:55从国内外指南共识看房颤抗凝治疗要点Main Points of Anticoagulation Treatment of Atrial Fibrillation from the Consensus of Domestic and Foreign Guidelines
-
10:55-11:00讨论Discussion
-
11:45-11:55讨论Discussion
-
10:00 - 11:00上半场First Half
-
11:00 - 12:00下半场Second Half